You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pegylated peptide drug

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Metastatic Trial in China (99mTc-3PRGD2)

Completed
  • Lung Cancer Metastatic
  • Beijing, Beijing, China
  • +3 more
Apr 25, 2022

Effect of Drug, Migraine Disorders Trial in Kafr Ash Shaykh (Lacosamide 50 mg)

Recruiting
  • Effect of Drug
  • Migraine Disorders
  • Lacosamide 50 mg
  • Kafr Ash Shaykh, Egypt
    Kafr Elsheikh University Hospital
Nov 20, 2022

Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

Recruiting
  • Leiomyosarcoma
  • Liposarcoma
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Nov 23, 2022

TAK-660 in Surgical Procedures for People With Hemophilia A.

Active, not recruiting
  • Hemophilia A
  • PEGylated Recombinant Factor VIII
  • Tokyo, Japan
    Takeda Selected Site
Dec 13, 2022

Idiopathic Intracranial Hypertension, Intracranial Pressure, Obesity Trial in Glostrup, Odense (drug, dietary supplement,

Recruiting
  • Idiopathic Intracranial Hypertension
  • +5 more
  • Glostrup, Denmark
  • +1 more
Sep 7, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +3 more
  • (no location specified)
Jan 18, 2023

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Bilaspur, Chhattisgarh, India
    YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021

HIV Trial in Chicago, Durham, Galveston (Interleukin-12, HIV-1 C4-V3 Polyvalent Peptide Vaccine)

Completed
  • HIV Infections
  • Chicago, Illinois
  • +2 more
Oct 28, 2021

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Diabetes, Type 1 Trial in Milan (Human pancreatic islet, ATG, Pegylated G-CSF)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Human pancreatic islet
  • +3 more
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Dec 1, 2022

Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in United States (TH1902)

Recruiting
  • Solid Tumor
  • +8 more
  • Los Angeles, California
  • +5 more
Jun 27, 2022

Pancreatic Cancer, Solid Tumors Trial run by the NCI (ProAgio)

Not yet recruiting
  • Pancreatic Cancer
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 26, 2021

Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7 Trial in United States

Recruiting
  • Breast Adenocarcinoma
  • +7 more
  • Multi-epitope HER2 Peptide Vaccine TPIV100
  • +5 more
  • Scottsdale, Arizona
  • +26 more
Aug 17, 2022

Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C, Chronic
  • Chennai, Tamil Nadu, India
    YR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021

Platinum-resistant Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • pegylated liposomal doxorubicin
  • (no location specified)
Aug 2, 2023

Breast Cancer Trial in Paris, Barcelone, Madrid (Trastuzumab and non-pegylated liposomal doxorubicin)

Completed
Has Results
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
Feb 8, 2022

Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

Completed
  • Advanced Ovarian Cancer
  • Sabadell, Barcelona, Spain
  • +7 more
Jan 25, 2023

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

Not yet recruiting
  • Lymphoma
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Apr 18, 2023

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

Completed
  • Leukemia, Chronic Lymphatic
  • Stuttgart, Baden-Wuerttemberg, Germany
  • +4 more
Nov 24, 2022

Hemophilia A Trial in Worldwide (Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method, PEGylated Recombinant Factor

Completed
  • Hemophilia A
  • Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
  • PEGylated Recombinant Factor VIII
  • Sofia, Bulgaria
  • +7 more
Apr 30, 2021